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Abstract
Background: The advancement of gene silencing via RNA interference is limited by the lack of
effective short interfering RNA (siRNA) delivery vectors. Rational design of polymeric carriers has
been complicated by the fact that most chemical modifications affect multiple aspects of the
delivery process. In this work, the extent of primary amine acetylation of generation 5
poly(amidoamine) (PAMAM) dendrimers was studied as a modification for the delivery of siRNA
to U87 malignant glioma cells.
Results: PAMAM dendrimers were reacted with acetic anhydride to obtain controlled extents of
primary amine acetylation. Acetylated dendrimers were complexed with siRNA, and physical
properties of the complexes were studied. Dendrimers with up to 60% of primary amines
acetylated formed ~200 nm complexes with siRNA. Increasing amine acetylation resulted in
reduced polymer cytotoxicity to U87 cells, as well as enhanced dissociation of dendrimer/siRNA
complexes. Acetylation of dendrimers reduced the cellular delivery of siRNA which correlated
with a reduction in the buffering capacity of dendrimers upon amine acetylation. Confocal
microscopy confirmed that escape from endosomes is a major barrier to siRNA delivery in this
system.
Conclusion: Primary amine acetylation of PAMAM dendrimers reduced their cytotoxicity to U87
cells, and promoted the release of siRNA from dendrimer/siRNA complexes. A modest fraction
(approximately 20%) of primary amines of PAMAM can be modified while maintaining the siRNA
delivery efficiency of unmodified PAMAM, but higher degrees of amine neutralization reduced the
gene silencing efficiency of PAMAM/siRNA delivery vectors.
Background
Since its discovery in 1998, RNA interference (RNAi) has
rapidly become a routine and powerful tool for use in
basic research and has also gained momentum in devel-
opment as a therapeutic [1-3]. While RNAi is an elegant,
endogenous and conserved mechanism to selectively
silence genes, inefficient delivery of exogenous short inter-
fering RNA (siRNA) molecules to cells and tissues remains
a barrier to its therapeutic development. As a result, the
design of effective siRNA delivery systems is crucial for the
clinical advancement of RNAi. Specifically, delivery vec-
tors must be designed to effectively complex with nucleic
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acid molecules and aid in overcoming intracellular barri-
ers such as endosomal escape and cytoplasmic vector dis-
sociation.
A variety of molecules including polymers, lipids, and
peptides have been studied for their effectiveness as deliv-
ery vectors for DNA and RNA molecules [4]. Successful
delivery vectors must exhibit a combination of functional
attributes. Polymeric carrier molecules should be cationic
to complex with nucleic acids, possess a high buffering
capacity, exhibit low cytotoxicity, and also contain chem-
ically reactive groups that can be modified for the addi-
tion of targeting moieties or other groups [4,5].
Highly branched, dendritic polymers including poly(ami-
doamine) (PAMAM) have recently attracted interest as
nucleic acid delivery vectors. Previous work has demon-
strated that dendrimers can bind to DNA and RNA mole-
cules and mediate modest cellular delivery of these
nucleic acids [6-9]. Recently, some studies have evaluated
the use of PAMAM dendrimers for successful delivery of
siRNA or antisense molecules. Generation 5 dendrimers
were found to have poor cellular delivery of siRNA to NIH
3T3 MDR cells, though they mediated moderately effec-
tive delivery of antisense oligonucleotides [10]. Another
study found that increasing the PAMAM dendrimer gener-
ation to seven to increase the number of primary amine
groups significantly enhanced siRNA delivery efficiency,
possibly by enhanced amine-induced pH buffering[11].
However, cytotoxicity of highly cationic dendrimers is a
marked problem that hinders their widespread use in drug
and gene delivery [6,7].
Thus, it is desirable to exploit the potential of PAMAM
dendrimers for nucleic acid delivery applications while
reducing their cytotoxicity. The cytotoxicity of dendrimers
can be reduced by conjugating hydrophilic polymers to
the periphery of the dendrimer [12-14], by conversion of
a fraction of the cationic amine groups to uncharged moi-
eties [15-17], or by modifying a neutrally charged den-
drimer with a few cationic amino acid groups sufficient to
facilitate nucleic acid complexation[18]. Since a wide vari-
ety of modifications exist to alter the properties of den-
drimers, the development of structure-activity
relationships will accelerate determination of the optimal
dendrimer properties for a particular application [19-21].
In this study, the effect of primary amine acetylation of the
cationic, dendrimeric polymer, PAMAM, on siRNA deliv-
ery was analyzed. Previous studies have shown that neu-
tralizing charges on the cationic polymer,
polyethylenimine (PEI), by amine acetylation enhanced
the transfection efficiency of plasmid DNA [22,23]. This
marked improvement in transfection efficiency correlated
with decreased polymer/DNA interactions, thus promot-
ing intracellular unpackaging of DNA from the polymer
[23]. Furthermore, amine acetylation of cationic polymers
is attractive since it has been shown to reduce cytotoxicity
in a variety of different cell lines [16,23]. We studied den-
drimer/siRNA interactions as well as the ability of
acetylated dendrimers to deliver siRNA to cells and elicit a
gene silencing effect. In addition, we evaluated the trade-
off between reduced polymer/siRNA interactions and
reduced endosomal buffering capacity. These design
parameters are important in the rational modification of
PAMAM dendrimers for siRNA delivery.
Results
Partial acetylation of PAMAM dendrimers
The primary amines of generation 5 (G5) PAMAM den-
drimers were acetylated by reaction with prescribed
amounts of acetic anhydride as depicted in Figure 1. 1H
NMR analysis of acetylated dendrimers was performed
using a method similar to that described previously[24].
Briefly, the fraction of primary amine acetylation was
determined by comparing the intensity of the peak at 1.87
ppm corresponding to -CH3 protons of the acetyl group to
the sum of all -CH2-peaks. The observed extents of amine
acetylation were very close to the theoretical maxima indi-
cated by reaction stoichiometry (Table 1). The acetylated
dendrimers are denoted by their experimentally deter-
mined acetylation levels as Ac20, Ac40, Ac60, and Ac84.
PicoGreen dye exclusion
The ability of acetylated dendrimers to complex with
siRNA as a function of polymer/siRNA charge ratio was
evaluated. The amount of unbound siRNA in solutions of
dendrimer/siRNA was determined by measuring the fluo-
rescence of a commercially available dye, PicoGreen, that
fluoresces upon binding to double-stranded DNA or RNA.
The fluorescence intensity decreased when increasing
amounts of polymer were added to a fixed amount of
siRNA, indicating association of siRNA with the polymer
Table 1: Extent of primary amine acetylation as determined by 1H NMR spectroscopy.
Sample (-CH3/-CH2-) ratio Number of acetyl groups added Percent of primary amine acetylation
Ac20 0.041 27 21.1
Ac40 0.075 50 39.1
Ac60 0.115 76 59.4
Ac84 0.16 107 83.6BMC Biotechnology 2009, 9:38 http://www.biomedcentral.com/1472-6750/9/38
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(Figure 2). At N/P = 1, differences in siRNA complexation
ability could be discerned, with higher fractions of siRNA
forming complexes with dendrimers possessing the
greater primary amine levels. However, by N/P = 10,
almost complete complexation of siRNA was observed for
unmodified dendrimer (G5), Ac20, Ac40, and Ac60. In con-
trast, the binding curve for the Ac84 polymer was shifted
markedly to the right, and little siRNA complexation was
observed at N/P = 10. Since the Ac84 dendrimer was not
able to complex with siRNA at N/P = 10, it was excluded
from further studies.
Complex size and zeta potential
Having demonstrated that acetylated dendrimers are able
to complex with siRNA, the characteristics of these com-
plexes were evaluated further by DLS and zeta potential
measurements. Particle size analysis by DLS showed the
formation of ~200 nm complexes between dendrimers
and siRNA, regardless of acetylation extent (Table 2).
Somewhat surprisingly, zeta potential measurements
were approximately equal (~40 mV) for siRNA complexes
with G5, Ac20, and Ac40 dendrimers. Though we do expect
the surface charge of these complexes to become less cati-
onic upon primary amine acetylation, this trend may not
be reflected in zeta potential measurements, as surface
charge has been shown to be non-linearly correlated to
zeta potential [25]. However, while the zeta potential of
dendrimer/siRNA complexes at N/P = 15 for G5, Ac20, and
Ac40 were approximately equal (~40 mV), the zeta poten-
tial did decrease somewhat for the Ac60/siRNA complex
(33 mV), indicating a modest change in the surface prop-
erties of this polyplex due to amine acetylation. This trend
is consistent with the dye exclusion results (Figure 2).
Heparin induced polyplex dissociation
Previous work has shown that more effective cellular
delivery of nucleic acids is achieved when polymers are
able to release or unpackage their cargo nucleic acid easily
following cellular entry [26]. To evaluate the effect of den-
drimer amine acetylation on polyplex dissociation, den-
drimer/siRNA complexes were challenged by exposure to
heparin sulfate, an anionic competitive binding agent.
Polyplexes were formed in solution at N/P = 10 and
exposed subsequently to either 20 μg/mL or 40 μg/mL of
heparin sulfate. After 60 minutes of incubation,
PicoGreen was used to measure the amount of siRNA
released from dendrimer polyplexes. As expected, more
siRNA was released from complexes with increasing
heparin concentration (Figure 3). Upon addition of
heparin, more siRNA was released from 25 kDa polyeth-
ylenimine (25K PEI), which was included as a well-stud-
Acetylation of PAMAM dendrimers Figure 1
Acetylation of PAMAM dendrimers. Acetic anhydride reacts with primary amines of G5 PAMAM dendrimers to produce 
acetylated PAMAM.
Effect of amine acetylation on siRNA complexation by  PicoGreen dye exclusion Figure 2
Effect of amine acetylation on siRNA complexation 
by PicoGreen dye exclusion. Complexes were prepared 
in PBS at a final siRNA concentration of 2 μg/mL. PicoGreen 
fluorescence correlates to unbound siRNA present in solu-
tion. Data represent mean ± SEM (n = 3).
Table 2: Particle diameter and zeta potential of dendrimer/
siRNA complexes
Sample Particle diameter (nm) Zeta Potential (mV)
G5-siRNA 200.2 ± 28.1 40.2 ± 1.1
Ac20-siRNA 226.2 ± 7.3 38.9 ± 0.9
Ac40-siRNA 229.3 ± 8.4 39.7 ± 0.7
Ac60-siRNA 173.7 ± 8.0 33.1 ± 0.8BMC Biotechnology 2009, 9:38 http://www.biomedcentral.com/1472-6750/9/38
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ied reference, than from G5 dendrimer, indicating that
25K PEI allows greater polyplex dissociation than G5 den-
drimer. Consistent with the decrease in cationic charge
density conferred by primary amine acetylation, the
amount of siRNA released increased with extent of pri-
mary amine acetylation. At high fractions (40 and 60%)
of amine acetylation, the polyplex dissociation of
acetylated dendrimers surpassed that of 25K PEI.
Cytotoxicity of acetylated dendrimers
Primary amine acetylation of various cationic polymers
has been shown to reduce their cytotoxicity [16,23]. The
cytotoxicity of acetylated dendrimers on a malignant gli-
oma cell line, U87, was evaluated by treatment with either
dendrimer/siRNA complexes (siRNA concentration = 100
nM) or with dendrimers in OptiMEM medium for 4 hours
(0.005 mM or 0.01 mM). Subsequently, cells were ana-
lyzed for cell viability using the MTS assay. Cells exposed
to OptiMEM medium alone were used as positive con-
trols. Minimal cytotoxicity was observed from treatment
with dendrimer/siRNA complexes at typical cell transfec-
tion conditions (Figure 4A). However, it is also important
to evaluate the cytotoxicity of the native polymers without
the presence of siRNA. In this case, a dose-dependent
cytotoxicity was observed by increasing the dendrimer
concentrations to higher concentrations than were used
Effect of amine acetylation on polyplex dissociation by  heparin competition Figure 3
Effect of amine acetylation on polyplex dissociation 
by heparin competition. Complexes (N/P = 10) were pre-
pared in PBS at a final siRNA concentration of 2 μg/mL, and 
were exposed to heparin for 60 min at 37°C. siRNA release 
from complexes was determined by PicoGreen fluorescence 
as in Figure 2. Data represent mean ± SEM (n = 5).
(A and B) – Cytotoxicity of dendrimer/siRNA complexes (A) and of acetylated dendrimers (B) Figure 4
(A and B) – Cytotoxicity of dendrimer/siRNA complexes (A) and of acetylated dendrimers (B). U-87 cells were 
exposed to dendrimer/siRNA complexes (siRNA concentration = 100 nM) or to dendrimers (0.005 or 0.01 mM) for 4 hours in 
OptiMEM medium prior to MTS viability assay. MTS absorbance measurements were normalized to cells receiving a mock 
treatment of OptiMEM medium only (100%). The unmodified, generation 5 dendrimer has 128 primary amines. Data represent 
mean ± SEM (n = 2 experiments, each measured in triplicate).BMC Biotechnology 2009, 9:38 http://www.biomedcentral.com/1472-6750/9/38
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for cell transfections (Figure 4B). Additionally, a linear
decrease in toxicity was observed upon reducing the
number of primary amines by acetylation. This trend is
consistent with previous work that showed a linear
decrease in cytotoxicity of a different cell type upon den-
drimer amine acetylation [16].
siRNA induced silencing of GFP in U87-d1EGFP cells
We tested the effectiveness of these polymers to deliver
anti-d1EGFP siRNAs to U87 cells stably expressing the
d1EGFP transgene. Cells were treated with dendrimer/
siRNA complexes for 4 hours at several charge ratios
within the range where all dendrimers (up to Ac60) are
able to complex the siRNA. After 24 and 48 hours, the
d1EGFP fluorescence of cells was analyzed using flow
cytometry. The fluorescence of polyplex treated cells was
normalized to time-matched U87-d1EGFP cells that
received a mock treatment of serum-free medium (posi-
tive control). SiRNAs delivered by unmodified G5 den-
drimer produced significant gene silencing, manifest in
reductions (up to 60% at a charge ratio of 20) of d1EGFP
fluorescence after 24 hours (Figure 5a). Upon primary
amine acetylation of dendrimers, a significant decrease in
GFP silencing efficiency was observed, particularly for the
dendrimer with the highest fractions of amine acetylation,
Ac40 (p = 0.0002) and Ac60 (p < 0.0001) compared to
unmodified dendrimer. The Ac20 dendrimer, with a mod-
est fraction of amine modification, produced an insignifi-
cant change in GFP silencing ability as compared to the
unmodified dendrimer (p = 0.28). For the G5 and Ac20
materials, an improved GFP silencing ability was observed
upon increasing the N/P ratio of each dendrimer from 10
to 20. The extent and trends of GFP silencing using these
polymers were maintained for 48 hours (data not shown).
A low level of non-specific GFP silencing (~20%) was
observed by all dendrimer/siRNA complexes delivering a
scrambled siRNA sequence.
Having studied the ability of acetylated dendrimers to
deliver siRNA to U87-d1EGFP cells to elicit a gene silenc-
ing response, we used fluorescently labeled (Cy3) siRNA
to determine intracellular levels of siRNA delivered by the
dendrimers to U87 cells that do not express d1EGFP. Pre-
vious work has shown that efficient gene silencing corre-
lates to high intracellular nucleic acid levels [27]. A
significant decrease in the intracellular fluorescence inten-
sity of siRNA was observed with increasing fractions of
amine acetylation (p < 0.0001 comparing Ac40 to G5 and
p < 0.0001 comparing Ac60 to G5) (Figure 5B). This trend
correlated closely to the decreased GFP silencing efficiency
upon amine acetylation (Figure 5A).
Confocal imaging
Confocal imaging was performed to compare the cellular
distribution of nucleic acids delivered by acetylated den-
drimers compared to unmodified dendrimers. As endo-
(A and B) – SiRNA-induced GFP silencing (A) and intracellular Cy3-siRNA levels (B) Figure 5
(A and B) – SiRNA-induced GFP silencing (A) and intracellular Cy3-siRNA levels (B). U-87-d1EGFP (A) or non-
transformed U-87 cells (B) were treated with PAMAM/siRNA complexes at a final siRNA concentration of 100 nM for 4 hours 
under serum-free conditions. Cells were analyzed using flow cytometry for GFP fluorescence (A) or Cy3 fluorescence (B) 24 
hours after the initial treatment. PolyFect (A) was used at 5:1 wt. ratio of PolyFect:siRNA. Data represent mean ± SEM (n = 3) 
(A) or (n = 1 experiment, measurements performed in triplicate) (B).BMC Biotechnology 2009, 9:38 http://www.biomedcentral.com/1472-6750/9/38
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somal escape is a well-known barrier to efficient nucleic
acid delivery [4,5], some transfections were performed in
the presence of chloroquine diphosphate, a buffering
agent, to identify if pH buffering is a significant barrier to
efficient siRNA delivery by acetylated dendrimers. Confo-
cal imaging indicated that oligodeoxynucleotides (ODNs)
delivered by PAMAM dendrimers were sequestered into
vesicles. Red ODN fluorescence appeared as isolated,
punctate specks when delivered by G5 or Ac60 dendrimers
(Figure 6a and 6b, respectively), with somewhat greater
cytoplasmic distribution observed for G5 delivery. These
distributions contrast with that of Lipofectamine2000, a
commercially available reagent, which delivered ODN
evenly throughout the cell (Figure 6h). Further, the pres-
ence of chloroquine diphosphate during transfection
mediated a homogeneous distribution of ODN in a frac-
tion of the cells when delivered by cationic dendrimers G5
(Figure 6e), Ac60 (Figure 6f), or 25K PEI (Figure 6g).
Titration of acetylated dendrimers
As the cellular distribution of ODN delivered by dendrim-
ers was improved by the presence of chloroquine in the
transfection medium, it is likely that endosomal escape is
a significant barrier to efficient siRNA delivery for
acetylated dendrimers. Hence, pH titrations were per-
formed to compare the buffering capacity of acetylated
dendrimers. Increasing the fraction of amine acetylation
caused titration curves to shift, indicating a reduction in
buffering capacity (Figure 7) upon addition of acid. This
trend is consistent with previous work performed with
acetylation of PEI [23]. Interestingly, the titration curve
showed that unmodified G5 PAMAM has a much lower
buffering capacity than 25 kDa PEI. While PAMAM and
PEI have similar numbers of amines per unit mass,
approximately half of the PAMAM amines are secondary
amines in the form of amide bonds that are not titratable.
Discussion
One motivation behind amine acetylation of PAMAM
dendrimers was to promote polymer-siRNA unpackaging
in cells. That is, self-assembled vectors for siRNA delivery
must associate strongly enough to remain intact during
cellular binding and entry, yet they must dissociate at
some point within cells to release their cargo. Previous
studies have identified vector unpackaging to be an
important barrier to polymeric gene and siRNA delivery
[23,26,28]. Specifically, correlations have been observed
between the release of DNA in competitive displacement
assays in vitro and transfection efficiency in cells [26]. Fur-
thermore, others have found that gene transfection was
improved by increasing fractions of amine acetylation of
PEI, and this result was attributed to decreased polymer-
DNA interactions resulting in enhanced intracellular poly-
plex dissociation [23]. Previous work by our group has
also reported a positive correlation between intracellular
oligonucleotide levels (and gene silencing) and enhanced
complex dissociation among various molecular weights of
PEI [27].
To reduce PAMAM/siRNA interactions in this work, we
employed partial amine acetylation of PAMAM dendrim-
Confocal microscopy images of Cy-5 labeled oligonucleotides  delivered to U-87-d1EGFP cells Figure 6
Confocal microscopy images of Cy-5 labeled oligonu-
cleotides delivered to U-87-d1EGFP cells. U-87-
d1EGFP cells were treated with polymer/Cy5-ODN com-
plexes (N/P = 15). Images show U-87-d1EGFP cells in green, 
and Cy5-ODN in red. Images represent cells transfected 
with: (a) G5 PAMAM; (b) Ac60 PAMAM; (c) 25K PEI; (d) 
OptiMEM medium only; (e) G5 PAMAM + 100 μM chloro-
quine; (f) Ac60 PAMAM + 100 μM chloroquine; (g) 25K PEI + 
100 μM chloroquine; and (h) Lipofectamine2000.
pH titrations Figure 7
pH titrations. Polymers were freshly dissolved in 5 mL of 
PicoPure water prior to titration. Polymer solutions were 
first titrated to pH~11.5 using 1 M NaOH. Five microliter 
aliquots of 1 M HCl were added to polymer solutions and 
the pH was recorded.BMC Biotechnology 2009, 9:38 http://www.biomedcentral.com/1472-6750/9/38
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ers. The heparin competition assay showed that unmodi-
fied generation 5 PAMAM dendrimer (molecular weight
~28 kDa) exhibited less dissociation of siRNA than did 25
kDa PEI. Given that 25K PEI possesses a high charge den-
sity and exhibits strong association with oligonucleotides
[27], the even greater resistance of G5 PAMAM to heparin
dissociation can be interpreted as indicating a poor ten-
dency of the dendrimer to dissociate from siRNA. As
hypothesized, greater dissociation was observed upon pri-
mary amine acetylation of PAMAM, which surpassed that
of 25 kDa PEI at a high fraction (60%) of primary amine
acetylation. However, polyplex size analysis demon-
strated that stable particles of high positive zeta potential
were formed between acetylated dendrimers and siRNA,
with a slight reduction in both at relatively high fraction
(60%) of primary amine acetylation. This suggests that
amine acetylation did not destabilize dendrimer/siRNA
complexes in isolation, but rather facilitated the ease of
dissociation of siRNA from the polymer complex in the
face of an anionic competitor.
In addition to promoting polyplex dissociation by amine
acetylation, we also expected to reduce cytotoxicity by par-
tial charge neutralization. Cytotoxicity often correlates
with a high charge density and is a marked problem with
highly cationic PAMAM dendrimers. Previous work has
shown a reduction in cytotoxicity upon amine acetylation
of cationic polymers [16]. Indeed, we observed a linear
decrease in cytotoxicity upon amine acetylation of
PAMAM dendrimers. Thus, "tuning" of cationic polymer
charge is a useful design principle in modulating both vec-
tor unpackaging and cytotoxicity.
Another important barrier to the cellular delivery of
nucleic acids is their sequestration in acidic endosomes.
Cationic polymers with titratable amines are thought to
mediate endosomal escape by buffering in the pH range
of 5–7, leading to osmotic pressure buildup and mem-
brane permeability via the "proton sponge" effect [29]. In
the current study, we found that primary amine acetyla-
tion somewhat decreased the pH buffering capacity of
dendrimers by removing primary amine groups. This
decrease in endosomal buffering capacity induced by
amine acetylation is likely responsible for the decreased
siRNA delivery, as the presence of a buffering agent
appeared to improve cellular distribution of oligonucle-
otides delivered by acetylated dendrimers.
It is important to note that acetylation of PEI has been
found to increase its ability deliver plasmid DNA [22,23]
in contrast to the present study in which amine acetyla-
tion of PAMAM either did not affect (at low extents) or
decreased (at high extents) the delivery of siRNA. Since
siRNAs are much shorter and thus less polyvalent than
plasmid DNA, it is likely that siRNA will more easily dis-
sociate from a cationic polymer than would a large, ani-
onic plasmid DNA, making polyplex dissociation a
potentially less critical step in the delivery process [30].
Further, it has been shown that the properties of poly-
plexes formed by dendrimers and RNA depend signifi-
cantly on the size of the RNA molecule with more stable
particles being formed with large RNA molecules due to
cooperative multivalent interactions[31]. These differ-
ences between polymers and their interactions with differ-
ent types of nucleic acids highlight the importance of
developing a more comprehensive and quantitative
understanding of intracellular delivery mechanisms and
their dependence on physicochemical attributes of the
polymer and nucleic acid, so that data from various deliv-
ery systems and studies can be interpreted and used to
rationally design nucleic acid carriers.
Conclusion
In summary, cationic dendrimers are promising architec-
tures for use as nucleic acid delivery vectors. Their highly
organized, cationic structure with functionalizable amine
groups provides them with molecular properties that are
favorable for efficient nucleic acid delivery. Neutralizing a
fraction of primary amines by acetylation in this study
did, as expected, promote polyplex unpackaging in vitro.
Additionally, a reduction in cytotoxicity was noticed upon
acetylation. However, a reduction in pH buffering was
also observed, possibly resulting in decreased siRNA
delivery to tumor cells. The addition of a buffering agent
chloroquine promoted favorable cellular distribution of
nucleic acids delivered by dendrimers, indicating that
endosomal escape is a substantial barrier to siRNA deliv-
ery by these polymers. Others efforts to modify PAMAM
dendrimers for gene or siRNA delivery have also reported
success in decreasing cytotoxicity but difficulties in achiev-
ing active nucleic acid delivery[15]. This observation dem-
onstrates both the importance of endosomal buffering to
siRNA delivery as well as the advantages of charge reduc-
tion including reduced cytotoxicity and enhanced vector
dissociation. The next generation of dendrimers for siRNA
delivery will need to integrate charge reduction of den-
drimers without compromising their endosomal buffer-
ing capacity.
Methods
Materials
A 22 nt anti-GFP siRNA sequence identified previously
[32] as an effective inhibitor of pd1EGFP expression
(sense strand: 5'-UUG UGG CCG UUU ACG UCG CCG
U-3', antisense strand: 3'-UGA ACA CCG GCA AAU GCA
GCG G-5') was utilized in this study. A scrambled siRNA
sequence (targeted against firefly luciferase) was used as a
negative control (sense strand: 5'-CUU ACG CUG AGU
ACU UCG A dTdT-3', antisense strand: 5'-UCG AAG UAC
UCA GCG UAA G dTdT-3'). The fluorescently labeled (5'BMC Biotechnology 2009, 9:38 http://www.biomedcentral.com/1472-6750/9/38
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Cy3 end modified on the sense strand) and unlabeled
sequences were purchased from Integrated DNA Technol-
ogies (Coralville, IA, USA). The control siRNA sequence
was purchased from Dharmacon (Lafayette, CO). The
lyophilized powder was resuspended to a concentration
of 20 μM (unlabeled siRNA) or 50 μM (Cy3 modified
sequence) according to the manufacturer's protocol
before use. Generation 5 PAMAM dendrimer was pur-
chased as a 5 wt% solution in methanol from Dendritech
(Midland, MI). Branched PEI of average molecular weight
25 kDa (Item 408727), acetic anhydride, triethylamine,
heparin sodium salt, and deuterium oxide (D2O) were
purchased from Sigma. PicoGreen fluorescent dye was
obtained from Molecular Probes (Eugene, OR, USA). MTS
reagent was purchased from Promega (Madison, WI,
USA). Unless otherwise stated, all cell culture products
were obtained from Invitrogen (Carlsbad, CA, USA).
Acetylation of PAMAM dendrimers
The molar ratio between acetic anhydride and PAMAM
dendrimer was adjusted to achieve 20, 40, 60, and 80% of
primary amines capped by an acetyl group. A 1:1 stoichi-
ometric ratio of primary amines: acetic anhydride was
used to achieve the desired extent of acetylation. Partially
acetylated dendrimers were prepared using the following
procedure: To 15 mL of anhydrous methanol in a magnet-
ically stirred round bottom flask, 5 mL of 5 wt% PAMAM
(0.214 g) in methanol was added. Triethylamine (10%
molar excess to acetic anhydride) was added to the flask
and was stirred for 30 minutes. The appropriate amount
of acetic anhydride was then added dropwise to the reac-
tion mixture and the reaction was carried out overnight at
room temperature under an argon atmosphere. The meth-
anol was then removed by vacuum, and the polymer resi-
due re-dissolved in distilled water. The polymer was then
dialyzed against 1 L of phosphate buffered saline (PBS)
for 8 hours followed by water overnight in a 10,000 kDa
cutoff Slide-A-Lyzer Dialysis cassette (Pierce Biotechnol-
ogy, Rockford, IL). The samples were then lyophilized and
stored at -20°C. Proton nuclear magnetic resonance (1H
NMR) spectra were taken in D2O using a Varian 400 MHz
or 500 MHz spectrophotometer, using the solvent as ref-
erence signal. The extent of primary amine acetylation was
determined using a previously described method[24].
PicoGreen assay for siRNA/PAMAM complexation
The complexes were prepared at various charge ratios by
mixing equal volumes of PAMAM with siRNA in PBS.
Charge ratios (N/P) were calculated as a ratio of the
number of primary amines in the polymer, determined
from 1H NMR spectra, to the number of anionic phos-
phate groups in the siRNA. The samples were then vor-
texed and incubated at room temperature for 15 minutes
to ensure complex formation. The complexes were pre-
pared at a final siRNA concentration of 0.2 μg of siRNA/
100 μL of solution. One hundred microliters of each com-
plex were transferred to a 96-well (black-walled, clear-bot-
tom, non-adsorbing) plate (Corning, NY, USA). A total of
100 μL of diluted PicoGreen dye (1:200 dilution in Tris-
EDTA (TE) buffer) was added to each sample. Fluores-
cence measurements were made after a 30 minute incuba-
tion at room temperature using a DTX800 Multimode
Detector (Beckman Coulter, CA, USA), at excitation and
emission wavelengths of 485 and 535 nm, respectively.
All measurements were corrected for background fluores-
cence from a solution containing only buffer and
PicoGreen dye.
Dynamic light scattering and zeta potential
Dynamic light scattering (DLS) and Zeta Potential analy-
ses were performed using a Malvern Instruments Zetasizer
Nano ZS-90 instrument (Southboro, MA) with reproduc-
ibility being verified by collection and comparison of
sequential measurements. Polymer/siRNA complexes
(siRNA concentration = 100 nM, N/P = 15) were prepared
using purified water (resistivity = 18.5 MΩ-cm). DLS
measurements were performed at a 90° scattering angle at
37°C. Z-average sizes of three sequential measurements
were collected and analyzed. Zeta potential measure-
ments were collected at 25°C, and the Z-average poten-
tials following three sequential measurements were
collected and analyzed.
Heparin competition assay
Complexes were prepared at a charge ratio of 10 as
described above (final siRNA concentration of 0.2 μg in a
total of 50 μL of solution) and were transferred to a 96-
well (black-walled, clear-bottom, non-adsorbing) plate. A
total of 100 μL of diluted PicoGreen dye was added to
each well, followed by the addition of 50 μL of heparin
solution prepared in TE buffer (pH = 8). The plate was
incubated for 60 minutes at 37°C, and fluorescence meas-
urements were then taken using the Multimode Detector
plate reader. The percentage of siRNA released was calcu-
lated as described previously [27].
Cell culture
U-87 MG cells (ATCC HTB-14) were maintained in D-
MEM medium supplemented with 10% fetal bovine
serum (FBS), L-glutamine, sodium pyruvate, non-essen-
tial amino acids, and penicillin-streptomycin solution. A
U-87 MG cell line containing a stably integrated destabi-
lized EGFP (d1EGFP) transgene was produced by trans-
fecting U-87 cells with the 4.9-kb pd1EGFP-N1 plasmid
(BD Biosciences Clontech, Palo Alto, CA) and maintained
under constant selective pressure by G418 (500 μg/mL).
All cell lines were cultivated in a humidified atmosphere
of 5% CO2 at 37°C.BMC Biotechnology 2009, 9:38 http://www.biomedcentral.com/1472-6750/9/38
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MTS cytotoxicity assay
U-87 cells were plated at a density of 103 cells/well in a 96-
well plate approximately 18 hours before the assay. Cells
were exposed to 100 μL of dendrimers or dendrimer/
siRNA complexes at various concentrations in OptiMEM
reduced serum medium (Invitrogen, Carlsbad, CA) for 4
hours. Twenty microliters of MTS reagent were added to
each sample using a multi-channel pipette, and the plate
was returned to the cell incubator for 2 hours. Absorbance
measurements were subsequently recorded at 490 nm
using a Bio-Rad Model 680 microplate reader (Hercules,
CA, USA). The values for treated samples were normalized
to those for cells receiving a mock treatment of OptiMEM
medium only (positive control).
siRNA delivery assay
U87 or U87-d1EGFP cells were plated at a density of 1.5 ×
105 cells/well in 12 well plates ~18 hours prior to transfec-
tion. Prior to treatment of cells, PAMAM/siRNA com-
plexes were prepared as described above in 200 μL of PBS.
PolyFect (Qiagen), a commercially available dendrimeric
transfection reagent, was used as a positive control. Trans-
fections were also performed with a scrambled siRNA
sequence not targeted against GFP to account for any non-
specific GFP silencing effects. Eight hundred microliters of
OptiMEM medium was mixed with each sample to obtain
a final siRNA concentration of 100 nM. The serum-con-
taining culture medium was aspirated from the cells, and
each well was treated with 1 mL of the PAMAM/siRNA
complexes in OptiMEM medium. After a 4 hour incuba-
tion period, the transfection mixture was replaced with
serum-containing culture medium and maintained under
normal growth conditions until the cells were assayed for
fluorescence by flow cytometry either 24 or 48 hours after
initial treatment. For cells being analyzed for GFP fluores-
cence, unlabeled siRNA was utilized. To determine intrac-
ellular siRNA levels, non-transformed U87 cells were
treated with Cy3-labeled siRNA.
Flow cytometry
Cells were washed with PBS, detached with trypsin-EDTA,
and collected in growth medium before they were pelleted
by centrifugation for 3.5 min at 200 g, and resuspended in
150 μL PBS. Samples were maintained on ice before being
subjected to flow cytometry analysis. Ten thousand cells
were analyzed on a FACSCalibur two-laser, four-color
flow cytometer (BD Biosciences) for GFP fluorescence
(FL-1) or Cy3 fluorescence (FL-2). CellQuest software was
used to acquire and analyze the results. Viable cells were
gated according to their typical forward/side scatter char-
acteristics.
Confocal microscopy
For confocal imaging, U87-d1EGFP cells were plated into
8-well Lab-Tek Chamber Slides (Lab-Tek, Naperville, IL)
at a density of 25,000 cells/well approximately 18 hours
prior to transfection. For imaging purposes, complexes of
PAMAM were prepared with a Cy5-labeled antisense oli-
gonucleotide targeted against GFP[32] (ODN concentra-
tion = 100 nM) to prevent fluorescence interference
between U-87-d1EGFP cells and Cy3-labeled siRNA, both
of which fluoresce in the green portion of the visible spec-
trum. Transfections were performed in the same manner
as for flow cytometry analysis. In some samples, 100 μM
of chloroquine diphosphate, a buffering agent, was added
to the transfection mixture. Imaging was performed at 63×
magnification with a Leica LCSSB2 confocal microscope
24 hours after transfection.
pH titrations
Either PAMAM or PEI (~4.5 mg) was freshly dissolved into
5 mL of purified water in a 10 mL beaker and was magnet-
ically stirred. pH measurements were taken using a NMR
tube micro pH probe (IQ Scientific, Carlsbad, CA). Using
1 N NaOH, solutions were adjusted to a pH of approxi-
mately 11.5. The polymer was then titrated by adding 5 μL
aliquots of 1N HCl until a total of 100 μL of HCl had been
added to the solution, at which point the pH had reached
a constant value of pH ~2. Titrations were each performed
in duplicate.
Statistics
All statistical comparisons among treatment groups were
performed using a one way ANOVA test with Tukey's all-
pairs post hoc comparison test.
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